Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Cabazitaxel by Zhuhai Beihai Biotech for Prostate Cancer: Likelihood of Approval
Cabazitaxel is under clinical development by Zhuhai Beihai Biotech and currently in Phase II for Prostate Cancer. According to GlobalData,...